MindMaze Therapeutics Holding (CHIX:MMTXZ) Total Liabilities: CHF13.19 Mil (As of Dec. 2025)


CHIX:MMTXZ MindMaze Therapeutics Holding SA CHIX:MMTXZ
15 GF Score
Price CHF0.21
! 2 Warning Signs
View Full Analysis

What is MindMaze Therapeutics Holding Total Liabilities?

MindMaze Therapeutics Holding CHIX:MMTXZ +4.74% 15 Total Liabilities is CHF13.19 Mil as of Dec. 2025. GuruFocus rates CHIX:MMTXZ with a GF Score™ of 15/100. The stock has 2 warning signs investors should review.

MindMaze Therapeutics Holding's Total Liabilities for the quarter that ended in Dec. 2025 was CHF13.19 Mil.

MindMaze Therapeutics Holding's quarterly Total Liabilities increased from . 20 (CHF0.00 Mil) to Dec. 2024 (CHF0.01 Mil) and increased from Dec. 2024 (CHF0.01 Mil) to Dec. 2025 (CHF13.19 Mil).

MindMaze Therapeutics Holding's annual Total Liabilities increased from . 20 (CHF0.00 Mil) to Dec. 2024 (CHF0.01 Mil) and increased from Dec. 2024 (CHF0.01 Mil) to Dec. 2025 (CHF13.19 Mil).

MindMaze Therapeutics Holding Total Liabilities Historical Data

* Premium members only.

The historical data trend for MindMaze Therapeutics Holding's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindMaze Therapeutics Holding Total Liabilities Chart

MindMaze Therapeutics Holding Annual Data
Trend Dec24 Dec25
Total Liabilities
0.01 13.19

MindMaze Therapeutics Holding Semi-Annual Data
Dec24 Dec25
Total Liabilities 0.01 13.19
CHIX:MMTXZ
15GF Score
MindMaze Therapeutics Holding SA CHIX:MMTXZ
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindMaze Therapeutics Holding Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

MindMaze Therapeutics Holding's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=10.93+(1.177+2.2204460492503E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1.082+0)
=13.19

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=51.53-38.341
=13.19

MindMaze Therapeutics Holding's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=10.93+(1.177+2.2204460492503E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1.082+0)
=13.19

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=51.53-38.341
=13.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of CHF13.19 Mil mean?
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a Total Liabilities of CHF13.19 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for MindMaze Therapeutics Holding and its competitors.
Is MindMaze Therapeutics Holding's Total Liabilities too high?
MindMaze Therapeutics Holding's current Total Liabilities is CHF13.19 Mil. Overall, MindMaze Therapeutics Holding has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does MindMaze Therapeutics Holding's Total Liabilities compare to VRTX and REGN?
MindMaze Therapeutics Holding's Total Liabilities of CHF13.19 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for MindMaze Therapeutics Holding and its competitors. MindMaze Therapeutics Holding's current Total Liabilities is CHF13.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindMaze Therapeutics Holding stock overvalued right now?
MindMaze Therapeutics Holding (CHIX:MMTXZ) has a current Total Liabilities of CHF13.19 Mil. The current Total Liabilities is CHF13.19 Mil. MindMaze Therapeutics Holding's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For MindMaze Therapeutics Holding (CHIX:MMTXZ), the current Total Liabilities is CHF13.19 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MindMaze Therapeutics Holding Business Description

Other Exchanges RLFTY:USAMMTX:Switzerland
Address Avenue de Secheron 15, Geneva, CHE, 1202
MindMaze Therapeutics Holding SA is a Swiss-based, commercial-stage biopharmaceutical and neurotechnology company. The company develops and commercializes digital treatments for neurological diseases and brain disorders. Its technology platform integrates software, sensors, and telehealth, and its solutions are used in clinical and home settings internationally. The company has developed evidence-based, next-generation neurotherapeutics that provide evidence-based motor and cognitive treatments to redefine clinical outcomes in patients with neurological disease and brain disorders. The company also manages Relief's existing portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic, and respiratory diseases.
15GF Score

Get the complete analysis for CHIX:MMTXZ

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF0.21
Price